Shopping Cart
- Remove All
- Your shopping cart is currently empty
ADG-106 is a fully human agonistic monoclonal IgG4 antibody targeting CD137 (4-1BB). It activates CD137 through a potent FcγRIIB-mediated cross-linking mechanism while antagonizing the CD137 ligand. The isotype control for ADG-106 can be referred to as HumanIgG4(S228P) kappa, Isotype Control.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | ADG-106 is a fully human agonistic monoclonal IgG4 antibody targeting CD137 (4-1BB). It activates CD137 through a potent FcγRIIB-mediated cross-linking mechanism while antagonizing the CD137 ligand. The isotype control for ADG-106 can be referred to as HumanIgG4(S228P) kappa, Isotype Control. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.